Chu Q - Search Results

1

Synergistic effects of metformin in combination with EGFR-TKI in the treatment of patients with advanced non-small cell lung cancer and type 2 diabetes.

Chen H, Yao W, Chu Q, Han R, Wang Y, Sun J, Wang D, Wang Y, Cao M, He Y. Chen H, et al. Among authors: chu q. Cancer Lett. 2015 Dec 1;369(1):97-102. doi: 10.1016/j.canlet.2015.08.024. Epub 2015 Sep 1. Cancer Lett. 2015. PMID: 26341687

2

Characterization of magnetic fluorescence Fe3O4/CdSe nanocomposites.

Du G, Liu Z, Wang D, Xia X, Jia L, Yao K, Chu Q, Zhang S. Du G, et al. Among authors: chu q. J Nanosci Nanotechnol. 2009 Feb;9(2):1304-7. doi: 10.1166/jnn.2009.c143. J Nanosci Nanotechnol. 2009. PMID: 19441511

3

Knockdown of the Bcl-2 gene increases sensitivity to EGFR tyrosine kinase inhibitors in the H1975 lung cancer cell line harboring T790M mutation.

Zou M, Xia S, Zhuang L, Han N, Chu Q, Chao T, Peng P, Chen Y, Gui Q, Yu S. Zou M, et al. Among authors: chu q. Int J Oncol. 2013 Jun;42(6):2094-102. doi: 10.3892/ijo.2013.1895. Epub 2013 Apr 12. Int J Oncol. 2013. PMID: 23588221

4

[Progress of platelet derived grow factor family in non-small cell lung cancer].

Tian Y, Chu Q, Chen Y. Tian Y, et al. Among authors: chu q. Zhongguo Fei Ai Za Zhi. 2014 Jan;17(1):42-8. doi: 10.3779/j.issn.1009-3419.2014.01.07. Zhongguo Fei Ai Za Zhi. 2014. PMID: 24398313 Free PMC article. Review. Chinese.

5

Relationship between the SER treatment period and prognosis of patients with small cell lung cancer.

Xiao XG, Wang SJ, Hu LY, Chu Q, Wei Y, Li Y, Mei Q, Chen Y. Xiao XG, et al. Among authors: chu q. Asian Pac J Cancer Prev. 2014;15(15):6415-9. doi: 10.7314/apjcp.2014.15.15.6415. Asian Pac J Cancer Prev. 2014. PMID: 25124635 Free article.

6

Meta-analysis reveals the correlation of Notch signaling with non-small cell lung cancer progression and prognosis.

Yuan X, Wu H, Xu H, Han N, Chu Q, Yu S, Chen Y, Wu K. Yuan X, et al. Among authors: chu q. Sci Rep. 2015 May 21;5:10338. doi: 10.1038/srep10338. Sci Rep. 2015. PMID: 25996086 Free PMC article.

7

Notch signaling: an emerging therapeutic target for cancer treatment.

Yuan X, Wu H, Xu H, Xiong H, Chu Q, Yu S, Wu GS, Wu K. Yuan X, et al. Among authors: chu q. Cancer Lett. 2015 Dec 1;369(1):20-7. doi: 10.1016/j.canlet.2015.07.048. Epub 2015 Sep 1. Cancer Lett. 2015. PMID: 26341688 Free article. Review.

8

Modification of platinum sensitivity by KEAP1/NRF2 signals in non-small cell lung cancer.

Tian Y, Wu K, Liu Q, Han N, Zhang L, Chu Q, Chen Y. Tian Y, et al. Among authors: chu q. J Hematol Oncol. 2016 Sep 6;9(1):83. doi: 10.1186/s13045-016-0311-0. J Hematol Oncol. 2016. PMID: 27601007 Free PMC article.

9

Estrogen receptor β1 activation accelerates resistance to epidermal growth factor receptor-tyrosine kinase inhibitors in non-small cell lung cancer.

Fu S, Liu C, Huang Q, Fan S, Tang H, Fu X, Ai B, Liao Y, Chu Q. Fu S, et al. Among authors: chu q. Oncol Rep. 2018 Mar;39(3):1313-1321. doi: 10.3892/or.2018.6186. Epub 2018 Jan 4. Oncol Rep. 2018. PMID: 29328407

10

EGFR-TKIs resistance via EGFR-independent signaling pathways.

Liu Q, Yu S, Zhao W, Qin S, Chu Q, Wu K. Liu Q, et al. Among authors: chu q. Mol Cancer. 2018 Feb 19;17(1):53. doi: 10.1186/s12943-018-0793-1. Mol Cancer. 2018. PMID: 29455669 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,505 results

Search Page

Filters